MedTrace Logo

Bronchoreversibility and Radiologic Morphology of Emphysema

NCT02008162 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-12-11

No results posted yet for this study

Summary

To assess response to bronchodilation with tiotropium plus salbutamol in patients with severe emphysema and analyze relationships between bronchoreversibility response and semiquantitative computed-tomography based emphysema severity measures.

Conditions

Interventions

DRUG

Bronchodilators

Administration of both albuterol and tiotropium bromide after a 48h period of washout from all bronchodilators, followed by spirometry and plethysmography

Sponsors & Collaborators

  • University of Rome Tor Vergata

    lead OTHER

Principal Investigators

  • Eugenio Pompeo, MD · Tor Vergata University

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02008162 on ClinicalTrials.gov